humanized ADCC cHAb18 antibody (Pacific Meinuoke/Fourth Military Medical University)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Namehumanized ADCC cHAb18 antibody (Pacific Meinuoke/Fourth Military Medical University)
Drug Alias NamecHAb18 mAb (Pacific Meinuoke/Fourth Military Medical University)HcHAb18meituozhu
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionBasigin inhibitors
TargetsBasigin
Therapy Area/IndicationsCarcinoma, Non-Small-Cell Lung
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesAir Force Medical University
China Registration ClassN/A

Develop Information

Active CompaniesJiangsu Pacific Minok Biopharmaceutical Co., Ltd.Air Force Medical University
Inactive CompaniesN/A
Active IndicationsCarcinoma, Non-Small-Cell Lung
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A